{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:49:24Z","timestamp":1779338964731,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"1p2","license":[{"start":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T00:00:00Z","timestamp":1048809600000},"content-version":"vor","delay-in-days":86,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p> <jats:bold>YOSHIDA, T., <jats:sc>et al<\/jats:sc>.: Bepridil Prevents Paroxysmal Atrial Fibrillation by a Class III Antiarrhythmic Drug Effect.<\/jats:bold>\n          <jats:italic>Background: Bepridil, a multiple ion\u2010channel blocker, has been reported to prevent paroxysmal atrial fibrillation (PAF). The f\u2010f interval of PAF during treatment with bepridil versus class Ic antiarrhythmic drugs was compared. Methods: Fifty\u2010two patients with PAF were randomized to bepridil, 200 mg\/day <\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(n = 14)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>versus flecainide, 100 to 200 mg\/day<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(n = 15)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>or pilsicainide, 75 to 150 mg\/day<\/jats:italic>\n          <jats:styled-content>(<jats:italic>n = 23)<\/jats:italic><\/jats:styled-content>\n          <jats:italic>. The drug was considered effective when symptomatic episodes of PAF were decreased to &lt; 50% during a follow\u2010up of 2 to 6 months. The f\u2010f interval was measured in 12\u2010lead ECGs of initial PAF episodes. Results: Bepridil and Ic were effective in 10 of 14 (71.4%) and 24 of 38 patients (63.2%), respectively (ns). In the Ic group, the f\u2010f interval was longer in successfully<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(114 \u00b1 48\u2003 ms)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>than in unsuccessfully<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(68 \u00b1 25\u2003 ms)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>treated patients<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(P = 0.002)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>. In the bepridil group, the f\u2010f interval was shorter in successfully<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(84 \u00b1 27\u2003 ms)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>than unsuccessfully<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(155 \u00b1 68\u2003 ms)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>treated patients<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(P = 0.015)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>. When comparing unsuccessfully treated patients, the f\u2010f interval in the bepridil group was significantly longer than in the Ic group<\/jats:italic>\n          <jats:styled-content>\n              <jats:italic>(P = 0.007)<\/jats:italic>\n            <\/jats:styled-content>\n          <jats:italic>. Conclusions: Bepridil was as effective as Ic drugs in the prevention of PAF. Because it was more effective in smaller (functional) than larger (anatomical) reentrant circuits, the effect of bepridil was considered to be mainly attributable to a class III antiarrhythmic action. (PACE 2003; 26[Pt. II]:314\u2013317)<\/jats:italic> <\/jats:p>","DOI":"10.1046\/j.1460-9592.2003.00040.x","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T08:02:53Z","timestamp":1104220973000},"page":"314-317","source":"Crossref","is-referenced-by-count":11,"title":["Bepridil Prevents Paroxysmal Atrial Fibrillation by a Class III Antiarrhythmic Drug Effect"],"prefix":"10.1111","volume":"26","author":[{"given":"TORU","family":"YOSHIDA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHI","family":"NIWANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIMIATSU","family":"INUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNKO","family":"SAITO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JISHO","family":"KOJIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUKO","family":"IKEDA\u2010MURAKAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDEYUKI","family":"HARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOHRU","family":"IZUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,3,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430050045005"},{"key":"e_1_2_5_3_2","first-page":"423","article-title":"Natural history of lone paroxysmal atrial fibrillation","volume":"65","author":"Enta K","year":"2001","journal-title":"Jpn Circ J"},{"key":"e_1_2_5_4_2","first-page":"423","article-title":"Investigation of the predictors of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation","volume":"65","author":"Koide Y","year":"2001","journal-title":"Jpn Circ J"},{"key":"e_1_2_5_5_2","unstructured":"YokomizoE AoyamaN AbeK et al.Four\u2010year follow up of paroxysmal atrial fibrillation patients. Jpn Circ J2001;65(suppl. I\u2010A):446."},{"key":"e_1_2_5_6_2","unstructured":"HirosawaK SekiguchiM KasanukiH et al.Natural history of atrial fibrillation. Heart Vessels1987; suppl.2:14\u201323."},{"key":"e_1_2_5_7_2","unstructured":"BraunwaldE ZipesDP LibbyP. Heart Disease Sixth Ed. Philadelphia ;W.B. SaundersCo. 2001."},{"key":"e_1_2_5_8_2","first-page":"203","article-title":"Evaluation of effect of antiarrhythmic on block coupling interval in the isthmus on a canine right atrium","volume":"63","author":"Niwano S","year":"1999","journal-title":"Jpn Circ J"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1831"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.63.1"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haisaguerre M","year":"1998","journal-title":"N Eng J M"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(64)90371-0"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.41.1.9"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/355349a0"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.81.5.753"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.9.3013"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.94.8.1962"},{"key":"e_1_2_5_18_2","first-page":"H356","article-title":"Meandering and unstable reentrant wave fronts induced by acetylcholine in isolated canine right atrium","volume":"273","author":"Ikeda T","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.62.1.51"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.62.2.395"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1998.tb01836.x"},{"key":"e_1_2_5_22_2","first-page":"129","article-title":"Effect of verapamil on the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. \u2010 Monitoring atrial refractoriness utilizing f\u2010f intervals","volume":"65","author":"Niwano S","year":"2001","journal-title":"Jpn Circ J"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.64.430"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00822-4"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.2.736"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.4.1689"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.71.2.271"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.3.1030"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1460-9592.2003.00040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1460-9592.2003.00040.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:59:57Z","timestamp":1697198397000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1460-9592.2003.00040.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":27,"journal-issue":{"issue":"1p2","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1460-9592.2003.00040.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1460-9592.2003.00040.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}